Laboratory Supply S...

Laboratory Supply Synthetic Huperzia Serrata Extract/Huperzine-A 99%

Laboratory Supply Synthetic Huperzia Serrata Extract/Huperzine-A 99%

Min.Order / FOB Price:Get Latest Price

0 Metric Ton

Negotiable

  • Min.Order :0 Metric Ton
  • Purity: 1-99%
  • Payment Terms : T/T,

Keywords

Huperzia Serrata Extract Huperzine-A 99% Huperzine-A

Quick Details

  • Appearance:light brown -Brown powder
  • Application:Huperzine A for enhancing memory, improving memory impairment, mental activity to improve the efficiency of age~related memory decline and Alzheimer's disease, juvenile learning disabilities and mem
  • PackAge:25kg/drum
  • ProductionCapacity:200|Kilogram|Month
  • Storage:
  • Transportation:

Superiority:

  1.12 Years Professional Huperzine-A Manufacturer 
   2. Factory has GMP certificate
   3. Have strict quality control system
   4.Quick transport

Details:

[Name of Product] : Huperzia Serrata Extract

[Latin Name] : Huperzia serratum

[Appearance]Brown Fine powder to White Fine Powder

[Specifications]:  1% 5% 98% 99% Huperzine-A 

[Part of Used]: Whole Plant 

[Form]:Powder 

[CAS-No]:  102518-79-6

[Molecular formula]:  C15H18N2O
[Molecular Weight]:  242.32

[Test Method]:HPLC 

[Solubility]Soluble in chloroform, soluble in methanol, ethanol, slightly soluble in water

[Clinical application]Huperzine A for enhancing memory, improving memory impairment, mental activity  to improve the efficiency of age~related memory decline and Alzheimer's disease, juvenile learning  disabilities and memory enhancement has significant improvement 

 

 

Huperzine-A is extracted from Huperzia serrata. It is a reversible acetylcholinesterase inhibitor and NMDA receptor antagonist that crosses the blood-brain barrier. The structure of the complex of huperzine A with acetylcholinesterase has been determined by X-ray crystallography.

For some years, huperzine A has been investigated as a possible treatment for diseases characterized by neurodegeneration – particularly Alzheimer's disease. A 2013 meta-analysis found that huperzine A may be efficacious in improving cognitive function, global clinical status, and activities of daily living for individuals with Alzheimer’s disease. However, due to the poor size and quality of the clinical trials reviewed, huperzine A should not be recommended as a treatment for Alzheimer’s disease until further high quality studies confirm its beneficial effects.

 

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View